8414 studies found for:    Communicable Diseases: Clinical Trials
Show Display Options
Rank Status Study
21 Not yet recruiting Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults
Condition: Malaria
Interventions: Biological: FMP012 with AS01B adjuvant system;   Other: P falciparum Controlled Human Malaria Infection (CHMI)
22 Recruiting Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Condition: Smallpox
Intervention: Biological: MVA-BN® smallpox vaccine
23 Completed Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
Condition: HIV Infections
Intervention: Drug: didanosine + lamivudine + efavirenz
24 Unknown  CATCH - Catheter Infections in Children
Condition: Catheter-Related Infections
Interventions: Device: Standard polyurethane Central Venous Catheter;   Device: Antibiotic impregnated polyurethane CVC (minocycline and rifampicin);   Device: Heparin bonded polyurethane CVC
25 Not yet recruiting Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria
Conditions: Bacteremia;   Healthcare-associated Pneumonia;   Ventilator-associated Pneumonia
Interventions: Drug: Polymyxin B;   Drug: Polymyxin B + Doripenem
26 Withdrawn Immune Response to Hepatitis C Virus
Conditions: Hepatitis C;   HIV Infections
Intervention: Other: None. Not a clinical trial. Specimens taken for basic research in laboratory.
27 Recruiting Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal Infection
Interventions: Drug: Mupirocin cream;   Drug: Mupirocin ointment
28 Withdrawn Factorial Trial of Antimicrobial Therapy and/or Catheter Change for Catheter-associated Urinary Tract Infections in the Critically Ill
Condition: Urinary Tract Infections
Interventions: Drug: Antimicrobial;   Device: Catheter change
29 Terminated
Has Results
Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)
Condition: Urinary Tract Infections
Interventions: Drug: MK0826 (ertapenem);   Drug: Comparator: meropenem
30 Recruiting Clinical Trial of Safety and Clinical Efficiency of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children
Condition: Acute Upper Respiratory Tract Infections
Interventions: Drug: Ergoferon;   Drug: Placebo
31 Completed A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Ampligen
32 Recruiting Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
Condition: Latent Tuberculosis Infection
Interventions: Drug: Isoniazid;   Drug: Rifampin
33 Recruiting A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial
Condition: Trachoma
Intervention: Other: Surveillance and treatment with azithromycin of newcomer and traveler families
34 Completed Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients
Condition: Catheter Related Bloodstream Infection
Intervention: Device: Chlorhexidine-impregnated foam dressing
35 Unknown  Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity
Conditions: Cesarean Section;   Surgical Wound Infection;   Endometritis
Interventions: Other: 80% inhaled oxygen via non-rebreather mask;   Other: 30% inhaled oxygen via nasal cannula
36 Completed
Has Results
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
Condition: Methicillin-resistant Staphylococcus Aureus
Intervention: Drug: Chlorhexidine bath and nasal mupirocin
37 Completed Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical Trial
Conditions: Acute Renal Failure;   Infection
Intervention: Other: Ethanol
38 Active, not recruiting A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh
Condition: Influenza
Interventions: Biological: SIIL Live Attenuated Influenza Vaccine;   Biological: Placebo
39 Terminated Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
Condition: Tuberculosis
Intervention: Drug: I ( isoniazid), II (isoniazid + rifampin )
40 Recruiting Clinical Trial of Safety and Clinical Efficiency of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adult Patients
Condition: Acute Upper Respiratory Tract Infections
Interventions: Drug: Ergoferon;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years